Independent ideas · analysis · useful context
KESTREL FOCUS
News · Analysis · Guides · Culture
A publication from A Wandering Mind
Essays, guides, reviews, and practical context across technology, money, science, culture, creative work, travel, and the ideas shaping everyday life.
Psilocybin and Mental Health: What the Evidence Shows in 2026
Psilocybin has reached Phase 3 research and an active FDA review pathway, but it is not an approved depression treatment. Here is what the evidence shows about depression, safety, microdosing, supervised treatment and what remains uncertain.
